16-year-old Estonian Ralf battles Duchenne muscular dystrophy as family fights for million-euro treatment

Ralf, a 16-year-old Estonian boy, was diagnosed with Duchenne muscular dystrophy at the age of three. The disease is considered the most severe form of muscular dystrophy in children, caused by a missing gene segment responsible for producing the muscle protein dystrophin. His family and caregivers are fighting to secure treatment that costs millions of euros.

Ralf, a 16-year-old boy from Estonia, has been living with Duchenne muscular dystrophy — the most severe form of childhood muscular dystrophy — since receiving his diagnosis at just three years old. The condition is caused by the absence of a gene segment responsible for producing dystrophin, a critical muscle protein, and progressively weakens the body's muscles over time.

Duchenne muscular dystrophy is a rare but devastating genetic disease that primarily affects boys. Without dystrophin, muscle fibres gradually break down and are replaced by fatty and fibrous tissue, leading to increasing weakness and, eventually, life-threatening complications affecting the heart and lungs. There is no cure, but emerging gene therapies and targeted treatments offer hope — at an enormous cost.

For Ralf's family and the network of caregivers supporting him, the financial barrier is one of the greatest obstacles they face. Treatments capable of targeting the underlying genetic cause of Duchenne's can cost millions of euros, placing them well beyond the reach of most families without public funding or private fundraising support.

Despite the challenges, those around Ralf have refused to give up. His supporters continue to raise awareness and push for access to life-changing therapies, hoping that public attention and advocacy will help secure the resources needed for his treatment.